Skip to content

Mark A. Geyer

53 papers in the library · 2,319 citations · publishing 1975-2026

Papers

Sort Most recent Most cited

Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.

Journal of Pain August 1, 2026 Jon G Dean, Ethan Hurwitz, T. Furnish et al.

Phantom limb pain (PLP) is a refractory condition defined by pain experienced in a missing limb. Psilocybin, a classical serotonergic psychedelic drug, can alleviate various treatment-resistant disorders but has scantly been investigated for chronic pain. This placebo-controlled, double-blind, randomized clinical pilot trial (NCT05224336) tested the feasibility, tolerability, and preliminary...

Metacognitive Feelings of Epistemic Gain are Central to the Understanding of Psychedelic-Induced Mystical-Type Experiences

Cognitive Therapy and Research March 29, 2025 Federico Seragnoli, Fabienne Picard, Gabriel Thorens et al. 4 citations

Abstract Purpose Despite the presence of mystical-type experiences in psychedelic-assisted therapy (PAT), an understanding of the cognitive processes involved is still lacking. Guided by theory and empirical research, we hypothesized a cognitive-grounded perspective based on current metacognition models to promote the understanding of the psychological processes involved in mystical-type...

DOI: 10.1007/s10608-025-10588-z (opens in new tab) Mysticism Metacognition Feeling Cognitive psychology +2

A Brief Historical Overview of Psychedelic Research.

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging May 1, 2024 Mark A. Geyer 30 citations

Classical serotonergic psychedelics such as lysergic acid diethylamide or the naturally occurring compounds psilocybin and mescaline produce profound changes in mood, thought, intuition, sensory perception, the experience of time and space, and even the experience of self. Research examining psychedelic compounds has had a complex and turbulent evolution. Many cultures throughout the world have...

HIV Transgenic Rats Demonstrate Impaired Sensorimotor Gating But Are Insensitive to Cannabinoid (Δ9-Tetrahydrocannabinol)-Induced Deficits.

The International Journal of Neuropsychopharmacology November 12, 2021 Benjamin Z Roberts, Arpi Minassian, Adam L. Halberstadt et al.

HIV-associated neurocognitive disorder (HAND) is commonly observed in persons living with HIV (PWH) and is characterized by cognitive deficits implicating disruptions of fronto-striatal neurocircuitry. Such circuitry is also susceptible to alteration by cannabis and other drugs of abuse. PWH use cannabis at much higher rates than the general population, thus prioritizing the characterization of...

The Relationship between Cannabis Use and Cognition in People with Bipolar Disorder: A Systematic Scoping Review

medRxiv April 29, 2020 T. Jordan Walter, Nina Pocuca, Jared W Young et al. 1 citation preprint

ABSTRACT Bipolar disorder (BD) and cannabis use are highly comorbid and are each associated with cognitive impairment. It is therefore important to understand the relationship between cannabis use and cognition in people with BD, as cannabis use in BD may be associated with greater cognitive impairment. We performed a scoping review to determine how much and what is currently known in this...

Serotonin and schizophrenia

Handbook of Behavioral Neuroscience 2020 Boris B. Quednow, Mark A. Geyer, Adam L. Halberstadt

Although the serotonin hypothesis of schizophrenia is one of the oldest neurochemical hypotheses on the pathogenesis of this disease, it is still highly topical. The concept of how the serotonin system is involved in the origin and progress of schizophrenia has considerably changed over the past decades. Therefore, the present work will give an overview about the development and the current...

Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen

Psychopharmacology February 14, 2019 Adam L. Halberstadt, Jochem V. F. Zee, Muhammad Chatha et al. 21 citations

Background There is evidence that mGlu2/3 receptors regulate 5-HT_2A signaling, interactions that have been theorized to play a role in the antipsychotic-like effects of mGlu2/3 agonists as well as the hallucinogenic effects of 5-HT_2A agonists. One approach to unraveling this interaction is through the chronic administration of agonists at the two receptors, which should influence the...

Premature responses in the five-choice serial reaction time task reflect rodents' temporal strategies: evidence from no-light and pharmacological challenges.

Psychopharmacology October 2016 Zackary A Cope, Adam L. Halberstadt, Jordy Van Enkhuizen et al.

The five-choice serial reaction time task (5-CSRTT) is regularly used to study attention and impulsivity. In the 5-CSRTT, rodents initiate a trial, then after an inter-trial interval (ITI), a light appears in one of five holes. Responding in the lit vs. unlit hole reflects attention (accuracy), while responding prematurely before a light appears is suggested to reflect impulsivity/response...

Effect of Hallucinogens on Unconditioned Behavior

Current Topics in Behavioral Neurosciences 2016 Mark A. Geyer, Adam L. Halberstadt 104 citations

Because of the ethical and regulatory hurdles associated with human studies, much of what is known about the psychopharmacology of hallucinogens has been derived from animal models. However, developing reliable animal models has proven to be a challenging task due to the complexity and variability of hallucinogen effects in humans. This chapter focuses on three animal models that are frequently...

DOI: 10.1007/7854_2016_466 (opens in new tab) Full text (opens in new tab) Hallucinogens Psychedelics Psychoactive substances Animal models +9

Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response.

Neuropharmacology February 1, 2014 Adam L. Halberstadt, Mark A. Geyer 113 citations

N-benzyl substitution markedly enhances the affinity of phenethylamine hallucinogens at the 5-HT(2A) receptor. N-benzyl substituted derivatives of 2,5-dimethoxy-4-iodophenethylamine (2C-I), such as N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (25I-NBOMe) and N-(2,3-methylenedioxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (25I-NBMD), have appeared recently as designer drugs, but have...

DOI: 10.1016/j.neuropharm.2013.08.025 (opens in new tab) Full text (opens in new tab) LSD Psychedelic pharmacology 5-ht2a receptor activation Head twitch response

Serotonergic hallucinogens as translational models relevant to schizophrenia

The International Journal of Neuropsychopharmacology August 13, 2013 Adam L. Halberstadt, Mark A. Geyer 66 citations

Abstract One of the oldest models of schizophrenia is based on the effects of serotonergic hallucinogens such as mescaline, psilocybin, and (+)-lysergic acid diethylamide (LSD), which act through the serotonin 5-HT2A receptor. These compounds produce a ‘model psychosis’ in normal individuals that resembles at least some of the positive symptoms of schizophrenia. Based on these similarities, and...

Role of the 5-HT₂A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice.

Neuropharmacology July 2013 Adam L. Halberstadt, Susan B Powell, Mark A. Geyer

The 5-HT₂A receptor mediates the effects of serotonergic hallucinogens and may play a role in the pathophysiology of certain psychiatric disorders, including schizophrenia. Given these findings, there is a need for animal models to assess the behavioral effects of 5-HT₂A receptor activation. Our previous studies demonstrated that the phenylalkylamine hallucinogen and 5-HT₂A/₂C agonist...

Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor.

Psychopharmacology June 1, 2012 Adam L. Halberstadt, David E Nichols, Mark A. Geyer 55 citations

Ayahuasca is a psychoactive tea prepared from a combination of plants that contain a hallucinogenic tryptamine and monoamine oxidase inhibitors (MAOIs). Behavioral pattern monitor (BPM) experiments demonstrated that the combination of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and a behaviorally inactive dose of an MAO(A) inhibitor such as harmaline or clorgyline induces biphasic effects on...

DOI: 10.1007/s00213-011-2616-6 (opens in new tab) Full text (opens in new tab) Neuropharmacology Drug metabolism Behavioral effects Pharmacological research

Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers

Neuropsychopharmacology September 28, 2011 Boris B. Quednow, Michael Kometer, Mark A. Geyer et al. 241 citations

The serotonin-2A receptor (5-HT(2A)R) has been implicated in the pathogenesis of schizophrenia and related inhibitory gating and behavioral inhibition deficits of schizophrenia patients. The hallucinogen psilocybin disrupts automatic forms of sensorimotor gating and response inhibition in humans, but it is unclear so far whether the 5-HT(2A)R or 5-HT(1A)R agonist properties of its bioactive...

Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.

Neuropharmacology January 20, 2011 Adam L. Halberstadt, Mark A. Geyer

Serotonergic hallucinogens produce profound changes in perception, mood, and cognition. These drugs include phenylalkylamines such as mescaline and 2,5-dimethoxy-4-methylamphetamine (DOM), and indoleamines such as (+)-lysergic acid diethylamide (LSD) and psilocybin. Despite their differences in chemical structure, the two classes of hallucinogens produce remarkably similar subjective effects in...

Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice

Psychopharmacology December 9, 2010 Adam L. Halberstadt, Virginia Lehmann-Masten, Mark A. Geyer et al. 35 citations

RATIONALE: Metabotropic glutamate (mGlu) receptors have been suggested to play a role in neuropsychiatric disorders including schizophrenia, drug abuse, and depression. Because serotonergic hallucinogens increase glutamate release and mGlu receptors modulate the response to serotonin (5-HT)(2A) activation, the interactions between serotonin 5-HT(2A) receptors and mGlu receptors may prove to be...

Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice

Journal of Psychopharmacology December 8, 2010 Liselore Koedood, Adam L. Halberstadt, Susan B Powell et al. 212 citations

Psilocin (4-hydroxy- N, N-dimethyltryptamine) is a hallucinogen that acts as an agonist at 5-HT 1A , 5-HT 2A , and 5-HT 2C receptors. Psilocin is the active metabolite of psilocybin, a hallucinogen that is currently being investigated clinically as a potential therapeutic agent. In the present investigation, we used a combination of genetic and pharmacological approaches to identify the...

LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor

Psychopharmacology November 24, 2009 Adam L. Halberstadt, Mark A. Geyer 76 citations

RATIONALE: Compounds that activate the 5-HT(2A) receptor, such as lysergic acid diethylamide (LSD), act as hallucinogens in humans. One notable exception is the LSD congener lisuride, which does not have hallucinogenic effects in humans even though it is a potent 5-HT(2A) agonist. LSD and other hallucinogens have been shown to disrupt prepulse inhibition (PPI), an operational measure of...

5-HT1A receptor activation is necessary for 5-MeODMT-dependent potentiation of feeding inhibition.

Pharmacology, Biochemistry, and Behavior September 1, 2009 Vikas Duvvuri, Victoria B Risbrough, Walter H. Kaye et al. 7 citations

We propose a translational approach to the study of anorexia nervosa (AN) based on our human subject studies where there are characteristic elevations in 5-HT(1A) receptor binding, associated harm avoidance behaviors, reduced impulsivity, and comorbid anxiety disorders. Towards this goal, the hyponeophagia assay was implemented whereby food-deprived mice show increased latency to begin feeding...

DOI: 10.1016/j.pbb.2009.05.014 (opens in new tab) Full text (opens in new tab) Anxiety stress Psychological distress Apprehension Food intake +8

A Kappa Opioid Model of Atypical Altered Consciousness and Psychosis: U50488, DOI, AC90179 Effects on Prepulse Inhibition and Locomotion in Mice

Journal of young investigators July 1, 2009 Michael A Ruderman, Susan B Powell, Mark A. Geyer

Sensorimortor gating and locomotion are behaviors that reflect pre-attentive sensory filtering and higher order, top-down, sensory processing, respectively. These processes are thought to affect either the perception of novelty in an environment (filtering) or cognition (higher order processing), salient features of models of altered states of consciousness (ASC). Drugs with highly selective...

5-HT_2A and 5-HT_2C Receptors Exert Opposing Effects on Locomotor Activity in Mice

Neuropsychopharmacology July 1, 2009 Adam L. Halberstadt, Iris Van der Heijden, Michael A Ruderman et al.

Although it is well established that hallucinogens act as 5-HT_2A and 5-HT_2C receptor agonists, little is known about the relative contributions of 5-HT_2A and 5-HT_2C receptors to the acute behavioral effects of these drugs. The behavioral pattern monitor was used to characterize the effects of the hallucinogen 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on locomotor and investigatory...

Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.

Psychopharmacology November 1, 2008 Adam L. Halberstadt, Mahalah R Buell, Virginia L Masten et al. 46 citations

The hallucinogenic tea known as ayahuasca is made from a combination of psychoactive plants that contribute the active components N,N-dimethyltryptamine (DMT) and 5-methoxy-DMT (5-MeO-DMT), as well as the monoamine oxidase (MAO) inhibitors (MAOIs) harmine and harmaline for oral activity. The present study examined the effects of 5-MeO-DMT in combination with MAOIs in rats using the behavioral...

Serotonin research: contributions to understanding psychoses

TIPS - Trends in Pharmacological Sciences August 1, 2008 Mark A. Geyer, Franz X. Vollenweider 435 citations

The history of serotonin research is closely related to the study of hallucinogenic drugs that function as agonists at serotonin-2A receptors. The fundamental idea that psychotic states seen in psychiatric disorders such as schizophrenia might be attributable, in part, to abnormalities in serotonergic systems began with the almost simultaneous discovery of lysergic acid diethylamide (LSD),...

Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition.

Biological Psychiatry January 1, 2008 Svetlana Semenova, Mark A. Geyer, J Gregor Sutcliffe et al.

Studies have implicated the serotonin (5-HT)(7) receptor in physiological and pathophysiological phenomena, including thermoregulation, central control of micturition and locomotion, regulation of circadian rhythm, sleep, and depression. Further, several antidepressant and antipsychotic drugs have high affinity for the 5-HT(7) receptor. We examined the role of 5-HT(7) receptors in a rodent...